Last updated on December 2018

Real-world Effectiveness of Adalimumab on Health Outcomes in Chinese Patients With Immune-Mediated Inflammatory Diseases


Brief description of study

The objective of this study is to evaluate the effect of adalimumab on health outcomes in participants with rheumatoid arthritis, ankylosing spondylitis and plaque psoriasis.

Clinical Study Identifier: NCT03339089

Contact Investigators or Research Sites near you

Start Over

Sun Fang

AbbVie China /ID# 164373
Shanghai, China
  Connect »

Sun Fang

Shenzhen Xiangmihu Hospital /ID# 209340
Shenzhen, China
  Connect »

Sun Fang

Jinhua Central Hospital /ID# 209339
Jinhua, China
  Connect »

Sun Fang

Sichuan Provincial orthopedic hospital /ID# 209341
Chengdu, China
  Connect »

Sun Fang

West China Hospital, SCU West China School of Medicine, SCU /ID# 209333
Chengdu, China
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.